Purchases and Sales Made in Q4 2023 in Evoke Pharma Inc (EVOK)
This table provides information about the institutional ownership of Evoke Pharma Inc (EVOK) during Q4 2023. The information is specifically focused on institutions that hold shares of Evoke Pharma Inc.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 13, 2024
Q4 2023
|
Tower Research Capital LLC (Trc)
New York, NY |
BUY
|
- |
653+ 11.27% |
$686 - $908
|
6.45K
$3.03K
|
|
|
Feb 13, 2024
Q4 2023
|
Morgan Stanley
New York, NY |
BUY
|
- |
375New |
$394 - $521
|
375
$176
|
|
|
Feb 09, 2024
Q4 2023
|
Ubs Group Ag
|
BUY
|
- |
207+ 7.65% |
$217 - $288
|
2.91K
$1.37K
|
|
|
Feb 09, 2024
Q4 2023
|
Wells Fargo & Company
San Francisco, CA |
BUY
|
- |
2+ 8.33% |
$2.1 - $2.78
|
26
$12.2
|
|
|
Feb 07, 2024
Q4 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Aug 14, 2024
Q4 2023
|
Federation Des Caisses Desjardins Du Quebec
Levis, A8 |
SELL
|
- |
-3- 60.0% |
$3.15 - $4.17
|
2
$0.94
|